Several mechanisms contribute to the abnormal fatty acid composition of serum phospholipids and cholesterol esters in cholestatic children with extrahepatic biliary atresia

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 56, Issue 3, 1997, Pages 199-204

  Robberecht, E ^a   Koletzko, B ^b   Christophe, A ^a,c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF MUNICH   (Germany)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; FATTY ACID;

ARTICLE; BILE DUCT ATRESIA; CHILD; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; LIPID BLOOD LEVEL; LIPID COMPOSITION; MALABSORPTION; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

EID: 0030942152     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90534-2     Document Type: Article

References (35)

1. Kasai M., Suzuki H., Ohashi E., Ori R., Chiba T., Okamoto A. Technique and results of operative management of biliary atresia. World J Surg 1978; 2: 571-579.
2. Mieli-Vergani G., Howard E. R., Portman B., Mowat A. P. Late referral for biliary atresia. Missed opportunities for elective surgery. Lancet 1989; i: 421-423.
3. Laurent J., Gautier F., Bernard O., Hadchouel M., Odivière M., Vabyer J., Alagille D. Long-term outcome after surgery for biliary atresia. Gastroenterol 1990; 99: 1793-1797.
4. Ohi R., Hanmatsu M., Mochizuki I., Chiba T., Kasai M. Progress in the treatment of biliary atresia. World J Surg 1985; 9: 285-293.
5. Kasai M., Mochizuki I., Ohkohchi N., Chiba T., Ohi R. Surgical limitation for biliary atresia: indication for liver transplantation. J Pediatr Surg 1989; 24: 851-854.
6. Lally K. P., Kanegaye J., Matsumura M., Rosenthal P., Sinatra F., Atkinson J. B. Perioperative factors affecting the outcome following repair of biliary atresia. Pediatrics 1989; 83: 723-726.
7. Kobayashi A., Ohbe Y., Yonekubo A. Fat absorption in patients with surgically repaired biliary atresia. Helv Paediatr Acta 1983; 38: 307-314.
8. Bojanovski M., Luckermann R., Schultz-Falten J., Sturm E., Burdelski M., Bojanovski D. Parameters of lipoprotein metabolism and cholestasis in healthy and cholestatic infants and children. Prog Lipid Res 1991; 30: 295-300.
9. Dupont J., Amédée-Manesme O., Pepin D., Chambaz J. Eicosanoid synthesis in children with cholestatic disease. J Inher Metab Dis 1990; 13: 212-218.
10. Shimizu T., Yamachiro Y., Yabuta K., Miyano T., Hayasawa H. Prostaglandin and fatty acid metabolism in patients with extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr 1990; 10: 298-302.
11. Gourley G. R., Farrell P. M., Odell G. B. Essential fatty acid deficiency after hepatic portoenterostomy for biliary atresia. Am J Clin Nutr 1982; 36: 1194-1199.
12. Yamashiro Y., Shimizu T., Ohtsuka Y., Nittono H., Miyano T., Kawakami S., Hayasawa H. Docosahexaenoic acid status of patients with extrahepatic biliary atresia. J Pediatr Surg 1994; 29: 1455-1458.
13. Decsi T., Koletzko B. Fatty acid composition of plasma lipid classes in healthy subjects from birth to young adulthood. Eur J Pediatr 1994; 153: 520-525.
14. Jendrassik L., Grof P. Vereinfachte photometrische Methoden zur Bestimmung des Blutbilirubins. Biochem Z 1938; 297: 81-89.
15. Christophe A., Robberecht E., De Baets F., Franckx H. Increase of long chain omega-3 fatty acids in the major serum lipid classes of patients with cystic fibrosis. Ann Nutr Metab 1992; 36: 304-312.
16. Anonymous. American Academy of Pediatrics Appendix K. In: Forbes G. B., ed. Pediatric Nutrition Handbook. Elk Grove Village, ILL: American Academy of Pediatrics 1985: 1.
17. Lands W. E. M., Libelt B., Morris A., Kramer N. C., Prewitt T. E., Bowen P., Schmeisser D., Davidson M. H., Burns J. H. Maintenance of lower proportions of (n-6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n-3) fatty acids. Biochim Biophys Acta 1992; 1180: 147-162.
18. Rubin M., Halpern Z., Charach G., Dvir A., Antebi E., Gilat T., Lichtenberg D. Effect of lipid infusion on bile composition and lithogenicity in patients without cholesterol gall stones. J Br Soc Gastroenterol 1992; 33: 1400-1403.
19. Blomstrand R., Ekdahl P. Fatty acid pattern of human bile under normal and pathological conditions. Proc Soc Exp Biol Med 1960; 104: 205-209.
20. Alling C., Cahlin E., Schersten T. Relationships between fatty acid patterns of serum, hepatic and biliary lecithins in man. Effect of sucrose feeding. Biochim Biophys Acta 1973; 296: 518-526.
21. Ritland S., Blomhoff J. P., Gjone E. Lecithin: cholesterol acyl-transferase and lipoprotein-X in liver disease. Clin Chim Acta 1973; 49: 251-259.
22. Christophe A. B., Warwick W. J., Holman R. T. Serum fatty acid profiles in cystic fibrosis patients and their parents. Lipids 1994; 29: 569-573.
23. Holman R. T., Johnson S. Changes in essential fatty acid profile of serum phospholipids in human disease. Progr Lipid Res 1981; 20: 67-73.
24. Innis S. M. Essential fatty acids in growth and development. Progr Lipid Res 1991; 30: 39-103.
25. Glomset J. A. The plasma lecithin: cholesterol acyltransferase reaction. J Lipid Res 1968; 9: 155-167.
26. Glomset J. A. Plasma lecithin: cholesterol acyltransferase. In: Nelson G. J., ed. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. New York, London, Sidney, Toronto: Wiley Interscience, 1972: 745-787.
27. Goodman D. S. The in vivo turn-over of individual cholesterol esters in human plasma lipoproteins. J Clin Invest 1964; 43: 2026-2036.
28. Subbaiah P. V., Liu M., Bolan P. J., Paltauf F. Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2arachydonoyl phosphatidyl cholines. Mechanism of formation of saturated cholesteryl esters. Biochim Biophys Acta 1992; 1128: 83-92.
29. Subbaiah P. V., Banerji B., Gregg R. E., Bagdade J. D. Molecular species of cholesteryl esters formed in abetalipoproteinemia: effect of apo B-containing lipoproteins. J Lipid Res 1990; 31: 927-932.
30. Goodman D. S., Shiratori T. Fatty acid composition of plasma lipoprotein fractions. J Lipid Res 1964; 5: 307-313.
31. Wengeler H., Seidel D. Does lipoprotein-X act as substrate for the lecithin:cholesterol acyltransferase? Clin Chim Acta 1973; 45: 429-432.
32. Wengeler H., Greten H., Seidel D. Serum cholesterol esterification in liver disease. Combined determinations of lecithin:cholesterol acyltransferase and lipoprotein-X. Europ J Clin Invest 1970; 2: 372-378.
33. Glomset J. R., Norum K. R. The metabolic role of lecithin:cholesterol acyltransferase:perspectives from pathology. Adv Lipid Res 1973; 11: 1-65.
34. Garrisson R. N., Cryer H. M., Howard D. A., Polk H. C. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199: 648-655.
35. Shaw B. W., Wood R. P., Gordon R D., Shunzaburo I., Guillquist W. P., Starzel T. E. Influence of selected patients variables and operative blood loss on six - month survival following liver transplantation. Sem Liver Dis 1985; 5: 385-393.